BriaCell Therapeutics Corp. (BCTX) stock

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ

Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30

$3.39−0.12 (-3.42%)

Close on Nov 13, 2026Market cap $29.60MP/E –Yield –

BriaCell Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

BriaCell Therapeutics's price to book ratio was 10.7× on Feb 28, 2023, against 4.2× a year earlier.

Period	Period end	Value	Change (pts)
2023	Feb 28, 2023	10.7×	+4.1
2022	Dec 30, 2022	6.6×	+2.0
2021	Dec 31, 2021	4.6×	–

See a number that looks wrong?